O'KANE KIERAN (Chief Commercial Officer) sold 6.2% of their position (584.00 shares) of BIODESIX INC on the open market
Open‑market sale worth $5.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/11/2026ACC: 0000905148-26-000635
Officer· Chief Commercial Officer
Since Oct 2020
-584.00
Net shares
Net seller
$5.9K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
1.60K acquired · 2.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.60K
Price / share
—
Trade value
—
% of position
20.3%
2/9/2026
7.87K→9.47K
Common Stock
Direct
Shares
−584.00
Price / share
$10.08
Trade value
$5.89K
% of position
6.2%
2/10/2026
9.47K→8.88K
Total
Net shares
+1.02K
Net value
-$5.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | M · Option Exercise | +1.60K | — | — | 20.3% | 7.87K | 9.47K |
| Common Stock Direct | 2/10/2026 | S · Sale | −584.00 | $10.08 | $5.89K | 6.2% | 9.47K | 8.88K |
| Total | +1.02K | -$5.89K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
73.00 shares
Shares
−73.00
Strike price
Held after
0.00
Exercisable
—
2/9/2026
Restricted Stock Units
Direct
Converts to
Common Stock
1.53K shares
Shares
−1.53K
Strike price
Held after
1.53K
Exercisable
—
2/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock73.00 shares | 2/9/2026 | M · Option Exercise | −73.00 | — | 0.00 | |
| Restricted Stock Units Direct | Common Stock1.53K shares | 2/9/2026 | M · Option Exercise | −1.53K | — | 1.53K |